AllHome bags ₹200 cr Series B at ₹2,000 cr valuation to scale building materials play
PharmEasy founders' home-and-interiors venture, backed by Bessemer, will deploy capital across experience centres, manufacturing and category expansion. At ₹400 cr ARR with 18-20% EBITDA margins, it targets ₹1,000 cr revenue over next 4-6 quarters in a fragmented $50 bn market.
AllHome, a tech-led building materials and interior products startup from PharmEasy founders, raised ₹200 crore Series B led by Bessemer at ₹2,000 crore valuation to expand experience centres, manufacturing and product categories across India's fragmented home market.
Why this matters
AllHome, founded by PharmEasy's founders, is doubling down on its house-of-brands play in home and interiors, with Bessemer leading a fresh ₹200 cr round at a ₹2,000 cr valuation.
Retail-company signals steady at 3,882 over the last 90 days.